NervGen Pharma Corp. (NGEN)

Market Open

1 Sep, 18:43

NASDAQ (CM)

$

2. 33

+0.12

+5.6561%

- Market Cap

- P/E Ratio

- Div Yield

765,475 Volume

0 Eps

$ 2.21

Previous Close

Investors:

Add Transaction

Day Range

2.1 2.36

Year Range

1.58 6.3

Want to track NGEN and more in your Portfolio? 🎯

Sign up for Marketlog, a portfolio tracker that will exceed your expectations!

Get Started For Free

NervGen Pharma Corp. Investors

Name	Quantity	Cost	Value	Profit ($)	Gain (%)
BZ Brandon Zatopek Commonwealth Equity Services LLC	33,000	$64,680	$56,430	-$8,250	-12.76%
PL Patrick Lannon VALLEY FORGE INVESTMENT CONSULTANTS Inc. ADV	10,000	$37,700	$17,100	-$20,600	-54.64%
NA Nizar Araji National Bank Of Canada /FI/	833	$3,140.41	$1,424.43	-$1,715.98	-54.64%
Anthony Scaramucci SkyBridge Capital II LLC	678,000	$1.33M	$1.18M	-$152,550	-11.48%
RWM Revisor Wealth Management LLC Revisor Wealth Management LLC	10,600	$20,776	$17,172	-$3,604	-17.35%
Taro Kuriyama Axq Capita LLP	43,099	$84,474.04	$71,544.34	-$12,929.7	-15.31%
PIL PFG Investments LLC PFG Investments LLC	217,500	$790,110	$352,350	-$437,760	-55.4%
Kevin Bresler TD Waterhouse Canada Inc.	23,800	$89,726	$38,556	-$51,170	-57.03%
SAM Smartleaf Asset Management LLC Smartleaf Asset Management LLC	3,656	$13,637	$6,434.56	-$7,202.44	-52.82%
Cynthia Schlanger Ashton Thomas Private Wealth, LLC	10,700	$40,339	$17,334	-$23,005	-57.03%
MA Marie-Andree Alain Federation des caisses Desjardins du Quebec	2,500	$4,900	$4,337.5	-$562.5	-11.48%

1

Blog Affiliate Program About Terms Privacy Help Contact Us

2026 © Marketlog. All Rights Reserved.